imatinib mesylate has been researched along with Adenomatoid Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conneally, E; Langabeer, S; Lynch, M; McCann, S; McMenamin, ME; Piccin, A | 1 |
1 other study(ies) available for imatinib mesylate and Adenomatoid Tumor
| Article | Year |
|---|---|
Adenomatoid tumor of the testis in a patient on imatinib therapy for chronic myeloid leukemia.
Topics: Adenomatoid Tumor; Adult; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines; Testicular Neoplasms | 2006 |